DAIICHI SANKYO CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,404 JPY | -0.33% |
|
+1.48% | +39.54% |
| May. 07 | Japan's Nikkei closes at 3-week high on US rate-cut outlook, tech boost | RE |
| May. 07 | Japan's Nikkei climbs on Fed rate-cut outlook, tech boost | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 1,602B 10.24B | Sales 2025 * | 1,767B 11.3B | Capitalization | 10,394B 66.45B |
|---|---|---|---|---|---|
| Net income 2024 | 201B 1.28B | Net income 2025 * | 195B 1.24B | EV / Sales 2024 | 5.72 x |
| Net cash position 2024 * | 556B 3.55B | Net cash position 2025 * | 603B 3.86B | EV / Sales 2025 * | 5.54 x |
| P/E ratio 2024 |
45.6
x | P/E ratio 2025 * |
52.8
x | Employees | 17,435 |
| Yield 2024 |
1.05% | Yield 2025 * |
1.11% | Free-Float | 97.04% |
More Fundamentals
* Assessed data
More news
Latest transcript on Daiichi Sankyo Co., Ltd.
More recommendations
More press releases
More news
| 1 day | -0.79% | ||
| 1 week | +1.03% | ||
| Current month | +0.28% | ||
| 1 month | +17.93% | ||
| 3 months | +12.67% | ||
| 6 months | +33.34% | ||
| Current year | +38.92% |
1 week
5 194.00
5 496.00
1 month
4 443.005 520.00
Current year
3 847.005 520.00
1 year
3 566.005 520.00
3 years
1 981.005 520.00
5 years
1 731.005 520.00
10 years
518.675 520.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sunao Manabe
CEO | Chief Executive Officer | 69 | 07-03-31 |
Hiroyuki Okuzawa
PSD | President | 61 | 17-03-31 |
Ken Takeshita
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sawako Nohara
BRD | Director/Board Member | 66 | 19-05-31 |
Kazuaki Kama
BRD | Director/Board Member | 75 | 19-05-31 |
Sunao Manabe
CEO | Chief Executive Officer | 69 | 07-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 25.16% | 19 M€ | +11.26% | ||
| 4.18% | 240 M€ | +15.33% | ||
| 3.32% | 174 M€ | -.--% | - | |
| 3.32% | 51 M€ | -.--% | - | |
| 3.24% | 14 M€ | +15.46% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 5,404 | -0.33% | 2 004 300 |
| 24-05-13 | 5,422 | +0.69% | 3,101,400 |
| 24-05-10 | 5,385 | +3.60% | 4,109,100 |
| 24-05-09 | 5,198 | -1.72% | 4,698,400 |
| 24-05-08 | 5,289 | -0.66% | 4,679,200 |
Delayed Quote Japan Exchange, May 14, 2024 at 12:13 am EDT
More quotes
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows:
- sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis;
- other (0.2%): primarily real estate activities.
Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Sector
Pharmaceuticals
Calendar
2024-07-30
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,422
JPY
Average target price
5,853
JPY
Spread / Average Target
+7.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +38.92% | 66.22B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
- Stock Market
- Equities
- 4568 Stock